of the shareholders attending the meeting and entitled to vote, excluding the votes of the shareholders having an interest from the calculation base. 2.2 Action to be taken by the Company in case there
the principal distribution channel that has been increasing consecutively, from the customer base expansion in accordance to the Company’s strategy, as well as the fact that the Company has begun
1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and
in various countries as mentioned above, which will help to expand the Company’ s customer base and welcome new types of customers of advertising business, and eventually the Company’s competitiveness
…………………………………….……… - provide a statement that the information in form 69-SUPPLEMENT-FD submitted to the Office of the Securities and Exchange Commission is considered to be a part of form 69- BASE-FD which becomes effective on
Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and
Indorama Ventures Public Company Limited 75/102 Ocean Tower 2, 37th Floor, Sukhumvit 19 (Wattana), Asoke Road, Klongtoey Nuer, Wattana, Bangkok 10110, Thailand Tel : +66(0)2 661 6661 Fax : +66(0)2
www.bangkokchainhospital.com บริษทั บางกอก เชน ฮอสปิทอล จ ากดั (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.158/2018 12 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which
www.bangkokchainhospital.com บริษัท บางกอก เชน ฮอสปิทอล จ ากัด (มหาชน) Bangkok Chain Hospital Public Company Limited No. BCH.172/2018 30 November 2018 Subject : Explanation of the change in operating results of Q3/2018 which
Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.2/2018, held on May 11, 2018, has approved the financial statements of the Company and its